1,136
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

Trends in Clostridioides difficile prevalence, mortality, severity, and age composition during 2003–2014, the national inpatient sample database in the US

&
Pages 1851-1858 | Received 05 Jan 2022, Accepted 16 Jun 2022, Published online: 04 Jul 2022

References

  • Johnson S, Samore MH, Farrow KA, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med. 1999;341(22):1645–1651.
  • Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539–1548.
  • Martin JS, Monaghan TM, Wilcox MH. Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol. 2016;13(4):206–216.
  • Rodriguez C, Van Broeck J, Taminiau B, et al. Clostridium difficile infection: early history, diagnosis and molecular strain typing methods. Microb Pathog. 2016;97:59–78.
  • Luo R, Barlam TF. Ten-year review of Clostridium difficile infection in acute care hospitals in the USA, 2005–2014. J Hosp Infect. 2018;98(1):40–43.
  • Shrestha MP, Bime C, Taleban S. Decreasing Clostridium difficile-associated fatality rates among hospitalized patients in the United States: 2004–2014. Am J Med. 2018;131(1):90–96.
  • Sumon ZE, Lesse AJ, Sellick JA, et al. Temporal trends of inpatient C. difficile infections within the Veterans Health Administration Hospitals: an analysis of the effect of molecular testing, time to testing, and mandatory reporting. Infect Control Hosp Epidemiol. 2020;41(1):44–51.
  • Depestel DD, Aronoff DM. Epidemiology of Clostridium difficile infection. J Pharm Pract. 2013;26(5):464–475.
  • Pepin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171(5):466–472.
  • Ricciardi R, Rothenberger DA, Madoff RD, et al. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg. 2007;142(7):624–631; discussion 31.
  • Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.
  • Joundi RA, Smith EE, Yu AYX, et al. Temporal trends in case fatality, discharge destination, and admission to long-term care after acute stroke. Neurology. 2021;96(16):e2037–e2047.
  • Olsen MA, Young-Xu Y, Stwalley D, et al. The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases. BMC Infect Dis. 2016;16:177.
  • Guh AY, Mu Y, Winston LG, Emerging Infections Program Clostridioides difficile Infection Working Group, et al. Trends in U.S. Burden of Clostridioides difficile infection and outcomes. N Engl J Med. 2020;382(14):1320–1330.
  • Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med. 2006;145(10):758–764.
  • Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–834.
  • Cheknis AK, Sambol SP, Davidson DM, et al. Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005–2007. Anaerobe. 2009;15(6):230–233.
  • Giancola SE, Williams RJ 2nd, Gentry CA. Prevalence of the Clostridium difficile BI/NAP1/027 strain across the United States Veterans Health Administration. Clin Microbiol Infect. 2017;24:877–881.
  • Snydman DR, McDermott LA, Jenkins SG, et al. Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016. Anaerobe. 2020;63:102185.
  • Tickler IA, Obradovich AE, Goering RV, et al. Changes in molecular epidemiology and antimicrobial resistance profiles of Clostridioides (Clostridium) difficile strains in the United States between 2011 and 2017. Anaerobe. 2019;60:102050.
  • Polage CR, Gyorke CE, Kennedy MA, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med. 2015;175(11):1792–1801.
  • Gould CV, Edwards JR, Cohen J, Clostridium difficile Infection Surveillance Investigators, Centers for Disease Control and Prevention, et al. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis. 2013;57(9):1304–1307.
  • Moehring RW, Lofgren ET, Anderson DJ. Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates. Infect Control Hosp Epidemiol. 2013;34(10):1055–1061.
  • Lessa FC, Gould CV, McDonald LC. Current status of Clostridium difficile infection epidemiology. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. Clin Infect Dis. 2012;55 Suppl 2:S65–S70.
  • Scheurer DB, Hicks LS, Cook EF, et al. Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort. Epidemiol Infect. 2007;135(6):1010–1013.
  • Juo YY, Sanaiha Y, Jabaji Z, et al. Trends in diverting loop ileostomy vs total abdominal colectomy as surgical management for Clostridium difficile colitis. JAMA Surg. 2019;154(10):899–906.